AGER and obesity disorder: We found that obesity in women is associated with increased expression of AGER in subcutaneous adipose tissue, whereas AGER-mediated development of metabolic inflammation—which predisposes to increased insulin resistance and T2DM—preferentially affects the visceral depot.